Strength training helps preserve muscle mass and supports bone health, which are both important considerations during weight loss
Participants also lost significantly more weight on semaglutide than placebo
25: 30493057 [DOI] [PubMed] [Google Scholar] 173.Seino Y, Rasmussen MF, Zdravkovic M, et al
Location: Plainsboro, New JerseyWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Wegovy (semaglutide) injection, for subcutaneous use, Ozempic (semaglutide) injection, for subcutaneous use, and Victoza (liraglutide) injection, for subcutaneous use.FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Novo Nordisk promoted Wegovy, Ozempic, and Victoza in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner
The idea is that tiny doses can give benefits with fewer side effects
